Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Cardiovascular Research|May 6, 2008
Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overloadStephanie Grote-Wessels, Hideo A Baba, Peter Boknik, et al.Scientific Reports|October 30, 2020
Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesotheliomaSabrina Borchert, Pia-Maria Suckrau, Robert F H Walter, et al.Oncotarget|June 2, 2018
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapyFabian D Mairinger, Jan Schmeller, Sabrina Borchert, et al.Journal of Cancer|October 5, 2016
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based ChemotherapyRobert Fred Henry Walter, Claudia Vollbrecht, Robert Werner, et al.Journal of Cancer|December 21, 2016
Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumorsRobert Fred Henry Walter, Claudia Vollbrecht, Daniel Christoph, et al.BMC Cancer|February 1, 2019
Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitroSabrina Borchert, Michael Wessolly, Jan Schmeller, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesotheliomaDaniel C Christoph, Bernadette Reyna Asuncion, Celine Mascaux, et al.Journal of Oncology|August 17, 2018
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53Robert F H Walter, Robert Werner, Michael Wessolly, et al.Immunobiology|November 23, 2016
Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survivalHana Guberina, Vera Rebmann, Bettina Wagner, et al.Journal of Cancer|August 27, 2014
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine TumoursFabian Dominik Mairinger, Robert Fred Henry Walter, Dirk Theegarten, et al.Pageof 10